{"id":1685,"date":"2019-06-10T09:31:21","date_gmt":"2019-06-10T07:31:21","guid":{"rendered":"https:\/\/www.nanexa.com\/?p=1685"},"modified":"2019-06-10T09:31:39","modified_gmt":"2019-06-10T07:31:39","slug":"1685","status":"publish","type":"post","link":"https:\/\/nanexa.com\/sv\/1685\/","title":{"rendered":"Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan"},"content":{"rendered":"<p><strong>Pressmeddelande <\/strong><\/p>\n<p>Uppsala 2019-06-10<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Nanexas PharmaShell<\/strong><strong><sup>\u00ae<\/sup><\/strong><strong>-patent godk\u00e4nt i Japan<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Japanska patentverket har godk\u00e4nt Nanexas patentans\u00f6kan avseende drug delivery-plattformen PharmaShell<sup>\u00ae<\/sup>.<\/p>\n<p>Nanexas drug delivery-system PharmaShell<sup>\u00ae\u00a0<\/sup>\u00e4r avpassad f\u00f6r parenteral administrering av l\u00e4kemedel. Drug delivery-systemet<sup>\u00a0<\/sup>m\u00f6jligg\u00f6r fris\u00e4ttning av l\u00e4kemedel p\u00e5 ett v\u00e4lkontrollerat s\u00e4tt fr\u00e5n ett par veckor till riktigt l\u00e5nga dep\u00e5tider p\u00e5 upp till ett \u00e5r. Dep\u00e5tiden kan, genom justeringar i tillverkningsprocessen av PharmaShell<sup>\u00ae<\/sup>, styras till \u00f6nskad l\u00e4ngd.<\/p>\n<p>PharmaShells<sup>\u00ae \u00a0<\/sup>egenskaper, med extremt h\u00f6g s\u00e5 kallad drug load och m\u00f6jlighet att styra den initiala fris\u00e4ttningen, g\u00f6r den unik p\u00e5 marknaden. Systemet m\u00f6jligg\u00f6r dep\u00e5beredningar av alltfr\u00e5n enkla sm\u00e5molekyl\u00e4ra l\u00e4kemedel till proteiner. De n\u00e4mnda egenskaperna \u00e4r efterfr\u00e5gade av l\u00e4kemedelsindustrin f\u00f6r att skapa nya och mer effektiva l\u00e4kemedel med m\u00f6jlighet att begr\u00e4nsa l\u00e4kemedlets biverkningar.<\/p>\n<p>Det japanska patentverket har godk\u00e4nt Nanexas patentans\u00f6kan den 30 maj 2019. Det nu godk\u00e4nda patentet t\u00e4cker in sj\u00e4lva produkten PharmaShell<sup>\u00ae <\/sup>samt metoden f\u00f6r dess tillverkning och formuleringar av PharmaShell<sup>\u00ae<\/sup>-belagda l\u00e4kemedel.\u00a0Det godk\u00e4nda patentet har patentnummer JP6516729.<\/p>\n<p>&nbsp;<\/p>\n<p><em>F\u00f6retagets VD David Westberg kommenterar:<\/em><\/p>\n<p><em>I januari fock vi PharmaShell\u00ae-patentet godk\u00e4nt i USA och jag kan nu konstatera att det \u00e4ven har godk\u00e4nts i Japan. Den japanska marknaden \u00e4r stor och viktig f\u00f6r Nanexa och med en godk\u00e4nd patentans\u00f6kan \u00f6kar v\u00e5ra kommersiella m\u00f6jligheter i framtiden. <\/em><\/p>\n<p><em>V\u00e5rt kontinuerliga arbete med patentans\u00f6kningarna b\u00f6rjar ge resultat och tillsammans med v\u00e5ra mer nyligt inl\u00e4mnade patentans\u00f6kningar bed\u00f6mmer jag att vi har en stark patentportf\u00f6lj. <\/em><\/p>\n<p><em>\u00a0<\/em><\/p>\n<p>F\u00f6r mer information kontakta:<\/p>\n<p>David Westberg \u2013 VD, Nanexa AB (publ)<\/p>\n<p>Telefon: 0709 -42 83 03<\/p>\n<p>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\">david.westberg@nanexa.se<\/a><\/p>\n<p>www.nanexa.com<\/p>\n<p>&nbsp;<\/p>\n<p>Om Nanexa AB (publ)<\/p>\n<p>Nanexa AB \u00e4r ett nanoteknologiskt drug deliveryf\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell<sup>\u00ae<\/sup>som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell<sup>\u00ae<\/sup>har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pressmeddelande <\/p>\n<p>Uppsala 2019-06-10<\/p>\n<p>\u00a0<\/p>\n<p>Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan<\/p>\n<p>&nbsp;<\/p>\n<p>Japanska patentverket har godk\u00e4nt Nanexas patentans\u00f6kan avseende drug delivery-plattformen PharmaShell\u00ae.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/1685\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-1685","post","type-post","status-publish","format-standard","hentry","category-pressmeddelanden"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/1685\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Pressmeddelande Uppsala 2019-06-10 \u00a0 Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan &nbsp; Japanska patentverket har godk\u00e4nt Nanexas patentans\u00f6kan avseende drug delivery-plattformen PharmaShell\u00ae.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/1685\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:published_time\" content=\"2019-06-10T07:31:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-06-10T07:31:39+00:00\" \/>\n<meta name=\"author\" content=\"Anders Johansson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders Johansson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/1685\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/1685\\\/\"},\"author\":{\"name\":\"Anders Johansson\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\"},\"headline\":\"Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan\",\"datePublished\":\"2019-06-10T07:31:21+00:00\",\"dateModified\":\"2019-06-10T07:31:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/1685\\\/\"},\"wordCount\":364,\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"articleSection\":[\"Pressmeddelanden\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/1685\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/1685\\\/\",\"name\":\"Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2019-06-10T07:31:21+00:00\",\"dateModified\":\"2019-06-10T07:31:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/1685\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/1685\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/1685\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\",\"name\":\"Anders Johansson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"caption\":\"Anders Johansson\"},\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/author\\\/anders\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/1685\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan - Nanexa AB","og_description":"Pressmeddelande Uppsala 2019-06-10 \u00a0 Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan &nbsp; Japanska patentverket har godk\u00e4nt Nanexas patentans\u00f6kan avseende drug delivery-plattformen PharmaShell\u00ae.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/1685\/","og_site_name":"Nanexa AB","article_published_time":"2019-06-10T07:31:21+00:00","article_modified_time":"2019-06-10T07:31:39+00:00","author":"Anders Johansson","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"Anders Johansson","Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanexa.com\/1685\/#article","isPartOf":{"@id":"https:\/\/nanexa.com\/1685\/"},"author":{"name":"Anders Johansson","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a"},"headline":"Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan","datePublished":"2019-06-10T07:31:21+00:00","dateModified":"2019-06-10T07:31:39+00:00","mainEntityOfPage":{"@id":"https:\/\/nanexa.com\/1685\/"},"wordCount":364,"publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"articleSection":["Pressmeddelanden"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/nanexa.com\/1685\/","url":"https:\/\/nanexa.com\/1685\/","name":"Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2019-06-10T07:31:21+00:00","dateModified":"2019-06-10T07:31:39+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/1685\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/1685\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/1685\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Nanexas PharmaShell\u00ae-patent godk\u00e4nt i Japan"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a","name":"Anders Johansson","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","caption":"Anders Johansson"},"url":"https:\/\/nanexa.com\/sv\/author\/anders\/"}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=1685"}],"version-history":[{"count":2,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1685\/revisions"}],"predecessor-version":[{"id":1687,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1685\/revisions\/1687"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=1685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/categories?post=1685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/tags?post=1685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}